Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis.
Agarwal A, Agrawal R, Raje D, Testi I, Mahajan S, Gunasekeran DV, Aggarwal K, Murthy SI, Westcott M, Chee SP, Mccluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham ET, Kempen JH, Nguyen QD, Pavesio C, Gupta V. Agarwal A, et al. Among authors: kempen jh. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):65-73. doi: 10.1080/09273948.2020.1761401. Epub 2020 Jun 26. Ocul Immunol Inflamm. 2020. PMID: 32589551
Epidemiology of Behçet disease.
Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Khairallah M, et al. Among authors: kempen jh. Ocul Immunol Inflamm. 2012 Oct;20(5):324-35. doi: 10.3109/09273948.2012.723112. Ocul Immunol Inflamm. 2012. PMID: 23030353 Review.
Adalimumab for Ocular Inflammation.
Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS Md Facs, Systemic Immunosuppressive Therapy For Eye Diseases Site Research Group. Durrani K, et al. Among authors: kempen jh. Ocul Immunol Inflamm. 2017 Jun;25(3):405-412. doi: 10.3109/09273948.2015.1134581. Epub 2016 Mar 22. Ocul Immunol Inflamm. 2017. PMID: 27003323 Free PMC article.
Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
Agrawal R, Gunasekeran DV, Grant R, Agarwal A, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study (COTS)–1 Study Group. Agrawal R, et al. JAMA Ophthalmol. 2017 Dec 1;135(12):1318-1327. doi: 10.1001/jamaophthalmol.2017.4485. JAMA Ophthalmol. 2017. PMID: 29075752 Free PMC article.
Design and Interpretation of Clinic-Based Studies in Uveitis.
Cunningham ET Jr, Acharya N, Kempen JH, Zierhut M. Cunningham ET Jr, et al. Among authors: kempen jh. Ocul Immunol Inflamm. 2015 Aug;23(4):267-270. doi: 10.3109/09273948.2015.1074028. Ocul Immunol Inflamm. 2015. PMID: 29265967 No abstract available.
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group. Dick AD, et al. Ophthalmology. 2018 May;125(5):757-773. doi: 10.1016/j.ophtha.2017.11.017. Epub 2018 Jan 6. Ophthalmology. 2018. PMID: 29310963 Free article.
234 results